• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高同型半胱氨酸血症与选择性经皮冠状动脉介入治疗后急性心肌梗死患者冠状动脉微循环阻力增加及短期预后不良的关系。

Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention.

机构信息

Department of Cardiology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.

出版信息

Biomed Res Int. 2020 Jan 2;2020:1710452. doi: 10.1155/2020/1710452. eCollection 2020.

DOI:10.1155/2020/1710452
PMID:31998781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6970506/
Abstract

BACKGROUND

This study aims to investigate the coronary microcirculatory resistance and prognosis of patients with acute myocardial infarction (AMI) concomitant with hyperhomocysteinemia (HHcy) after an elective percutaneous coronary intervention (PCI).

METHODS

A total of 101 patients that underwent elective PCI between May 2015 and July 2018 due to AMI were consecutively enrolled in this study. Patients were divided into a HHcy group (53) and a normal Hcy group (control; 48) based on their plasma homocysteine concentration. The characteristics of coronary angiography, the index of microcirculatory resistance (IMR) of infarct-related vessels (IRV), changes in left ventricular end diastolic diameter (LVEDd) and left ventricular ejection fraction (LVEF) before and after PCI, and the incidence of major adverse cardiovascular events (MACE) three months after PCI were compared between these groups.

RESULTS

Compared to the results from the Hcy group, the HHcy group had a higher IMR. The HHcy group had significantly higher LVEDd and a lower LVEF than the Hcy group 3 months after PCI. Additionally, the incidence of MACE at three months after PCI was higher in the HHcy group than in the Hcy group. Pearson correlation analysis revealed a positive correlation with IMR in the HHcy group. Furthermore, there was a difference in the LVEDd measured at one day after PCI and at three months after PCI in the HHcy group.

CONCLUSION

AMI patients concomitant with HHcy that undergo elective PCI are prone to coronary microcirculatory dysfunction and have a poor cardiac function and poor prognosis at three months after PCI.

摘要

背景

本研究旨在探讨择期经皮冠状动脉介入治疗(PCI)后伴高同型半胱氨酸血症(HHcy)的急性心肌梗死(AMI)患者的冠状动脉微循环阻力和预后。

方法

连续纳入 2015 年 5 月至 2018 年 7 月因 AMI 接受择期 PCI 的 101 例患者。根据血浆同型半胱氨酸浓度,将患者分为 HHcy 组(53 例)和正常 Hcy 组(对照组;48 例)。比较两组患者冠状动脉造影特点、梗死相关血管(IRV)的微循环阻力指数(IMR)、PCI 前后左心室舒张末期直径(LVEDd)和左心室射血分数(LVEF)的变化以及 PCI 后 3 个月主要不良心血管事件(MACE)的发生率。

结果

与 Hcy 组相比,HHcy 组的 IMR 更高。PCI 后 3 个月,HHcy 组的 LVEDd 明显升高,LVEF 明显降低。此外,HHcy 组 PCI 后 3 个月的 MACE 发生率高于 Hcy 组。Pearson 相关分析显示,HHcy 组 IMR 与 LVEDd 呈正相关。此外,HHcy 组 PCI 后 1 天和 3 个月的 LVEDd 测量值存在差异。

结论

行择期 PCI 的伴 HHcy 的 AMI 患者易发生冠状动脉微循环功能障碍,PCI 后 3 个月心功能较差,预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c91/6970506/f2961a35c78c/BMRI2020-1710452.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c91/6970506/f2961a35c78c/BMRI2020-1710452.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c91/6970506/f2961a35c78c/BMRI2020-1710452.001.jpg

相似文献

1
Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention.高同型半胱氨酸血症与选择性经皮冠状动脉介入治疗后急性心肌梗死患者冠状动脉微循环阻力增加及短期预后不良的关系。
Biomed Res Int. 2020 Jan 2;2020:1710452. doi: 10.1155/2020/1710452. eCollection 2020.
2
Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.经皮冠状动脉介入治疗稳定型心绞痛患者冠状动脉微循环再灌注不佳的情况。
J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):733-741.
3
[Feasibility and value of index of microcirculatory resistance in patients with acute myocardial infarction after primary percutaneous coronary intervention].[急性心肌梗死患者直接经皮冠状动脉介入治疗后微循环阻力指数的可行性及价值]
Zhonghua Yi Xue Za Zhi. 2017 Aug 1;97(29):2261-2265. doi: 10.3760/cma.j.issn.0376-2491.2017.29.006.
4
Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者中冠状动脉内应用尿激酶原的疗效及安全性:一项随机对照研究。
BMC Cardiovasc Disord. 2020 Jun 26;20(1):308. doi: 10.1186/s12872-020-01584-0.
5
The relationship between homocysteine and cardiopulmonary exercise testing in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征患者同型半胱氨酸与心肺运动试验的关系。
BMC Cardiovasc Disord. 2023 Jan 6;23(1):3. doi: 10.1186/s12872-022-02976-0.
6
Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction.基于微血管阻力指数和左心室舒张末期压力的急性心肌梗死风险分层。
Circ Cardiovasc Interv. 2021 Feb;14(2):e009529. doi: 10.1161/CIRCINTERVENTIONS.120.009529. Epub 2021 Feb 16.
7
Effects of atorvastatin combined with bivalirudin on coagulation function, cardiac function, and inflammatory factors of percutaneous coronary intervention in elderly patients with acute myocardial infarction.阿托伐他汀联合比伐卢定对老年急性心肌梗死患者经皮冠状动脉介入治疗凝血功能、心功能及炎症因子的影响。
Ann Palliat Med. 2020 Jul;9(4):1905-1911. doi: 10.21037/apm-20-925. Epub 2020 Jun 22.
8
Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI.微血管阻力指数预测 STEMI 患者行直接经皮冠状动脉介入治疗后长期心收缩功能。
BMC Cardiovasc Disord. 2021 Feb 2;21(1):66. doi: 10.1186/s12872-021-01887-w.
9
Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.经皮冠状动脉介入治疗后微循环阻力指数对非 ST 段抬高型急性冠状动脉综合征患者的预后价值。
Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1063-1074. doi: 10.1002/ccd.27529. Epub 2018 Feb 15.
10
[Predictive value of myocardial contrast echocardiography in evaluating myocardial perfusion and prognosis after percutaneous coronary intervention in patients with acute myocardial infarction].[心肌对比超声心动图在评估急性心肌梗死患者经皮冠状动脉介入治疗后心肌灌注及预后中的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Oct 24;52(10):1186-1192. doi: 10.3760/cma.j.cn112148-20231007-00219.

引用本文的文献

1
Homocysteinylation of Fibrinogen: A Post-Translational Link to Thrombosis.纤维蛋白原的同型半胱氨酸化:血栓形成的一种翻译后联系。
Int J Mol Sci. 2025 Jun 7;26(12):5471. doi: 10.3390/ijms26125471.
2
Surgical outcomes following encephaloduroarteriosynangiosis in moyamoya disease associated with hyperhomocysteinemia.镰状细胞贫血伴同高同型半胱氨酸血症患者行颅内外血管搭桥术后的手术效果。
Brain Behav. 2023 Aug;13(8):e3093. doi: 10.1002/brb3.3093. Epub 2023 Jun 29.
3
Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

本文引用的文献

1
Acute Myocardial Infarction.急性心肌梗死
N Engl J Med. 2017 May 25;376(21):2053-2064. doi: 10.1056/NEJMra1606915.
2
Prognostic impact of homocysteine levels and homocysteine thiolactonase activity on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.同型半胱氨酸水平和同型半胱氨酸硫内酯酶活性对接受经皮冠状动脉介入治疗患者长期临床结局的预后影响。
J Cardiol. 2017 Jun;69(6):830-835. doi: 10.1016/j.jjcc.2016.08.013. Epub 2016 Sep 28.
3
Inhibition of hydrogen sulfide on the proliferation of vascular smooth muscle cells involved in the modulation of calcium sensing receptor in high homocysteine.
高同型半胱氨酸血症是成年烟雾病患者术后缺血的一个危险因素。
Neurosurg Rev. 2021 Oct;44(5):2913-2921. doi: 10.1007/s10143-021-01482-9. Epub 2021 Jan 27.
4
Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study.同型半胱氨酸与老年人群心血管事件及全因死亡风险:一项基于社区的前瞻性队列研究
Ther Clin Risk Manag. 2020 May 22;16:471-481. doi: 10.2147/TCRM.S239496. eCollection 2020.
硫化氢对高同型半胱氨酸血症中参与钙敏感受体调节的血管平滑肌细胞增殖的抑制作用。
Exp Cell Res. 2016 Sep 10;347(1):184-191. doi: 10.1016/j.yexcr.2016.08.004. Epub 2016 Aug 5.
4
Prognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease: A Propensity Score Matched Analysis.韩国冠状动脉疾病患者中同型半胱氨酸水平升高的预后价值:一项倾向评分匹配分析
Korean Circ J. 2016 Mar;46(2):154-60. doi: 10.4070/kcj.2016.46.2.154. Epub 2016 Mar 21.
5
The Human Microcirculation: Regulation of Flow and Beyond.人体微循环:血流调节及其他
Circ Res. 2016 Jan 8;118(1):157-72. doi: 10.1161/CIRCRESAHA.115.305364.
6
Coronary microvascular obstruction in acute myocardial infarction.急性心肌梗死中的冠状动脉微血管阻塞。
Eur Heart J. 2016 Apr 1;37(13):1024-33. doi: 10.1093/eurheartj/ehv484. Epub 2015 Sep 12.
7
Homocysteine-lowering interventions for preventing cardiovascular events.降低同型半胱氨酸水平预防心血管事件的干预措施。
Cochrane Database Syst Rev. 2015 Jan 15;1:CD006612. doi: 10.1002/14651858.CD006612.pub4.
8
Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials.叶酸补充剂联合或不联合维生素 B6 与血管再通风险:一项随机对照试验的荟萃分析。
Clin Nutr. 2014 Aug;33(4):603-12. doi: 10.1016/j.clnu.2014.01.006. Epub 2014 Jan 12.
9
Homocysteine and other cardiovascular risk factors in patients with lichen planus.扁平苔藓患者的同型半胱氨酸及其他心血管危险因素
J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1507-13. doi: 10.1111/jdv.12329. Epub 2013 Dec 12.
10
Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗后测量的微血管阻力指数的预后价值。
Circulation. 2013 Jun 18;127(24):2436-41. doi: 10.1161/CIRCULATIONAHA.112.000298. Epub 2013 May 16.